The Serum Institute of India will invest GBP 240 million in the UK to expand its

vaccine business and set up a new sales office creating a large number of jobs,
Downing Street has announced as part of plans for a GBP 1 billion India-UK
Enhanced Trade Partnership creating around 6,500 jobs in Britain.
The Pune-based vaccine manufacturer is among a list of nearly 20 Indian
companies across sectors such as healthcare, biotech and software services to
announce significant investment plans in the UK.
MORE FROM THIS SECTIONSee All

Reliance Industries' balance sheet deleveraging continues: S&P

1 min read . 02:10 PM IST

We’re taking a pause to heal, says Godrej Properties

1 min read . 11:08 AM IST

Apple rolls out second ad slot to App Store, expanding business

1 min read . 05:51 AM IST

Pfizer sees Covid-19 as 'durable' revenue stream as profits rise

3 min read . 05:27 AM IST

It was also revealed that the Serum Institute of India (SII) has started phase one
trials in the UK of a nasal vaccine against coronavirus.
“The sales office is expected to generate new business worth over USD 1 billion,
GBP 200 million of which will be invested into the UK," Downing Street said on
Monday in reference to SII's plans for the UK market.
“Serum’s investment will support clinical trials, research and development and
possibly manufacturing of vaccines. This will help the UK and the world to defeat
the coronavirus pandemic and other deadly diseases. Serum has already started
phase one trials in the UK of a one-dose nasal vaccine for coronavirus, in
partnership with Codagenix INC," it said.
In the field of healthcare, another Indian investment highlight includes GBP 59
million by biotech firm Global Gene Corp over the next five years.
It will create 110 highly skilled jobs in the UK, mostly based in the R&D centre at
Wellcome Genome Campus in Cambridge, which is the site of the Human Genome
Project.
“I’m very pleased that Global Gene Corp has decided to join the legions of Indian
companies investing in the UK, boosting our healthcare sector and driving
economic growth," said UK Prime Minister Boris Johnson in a statement.
TRENDING STORIESSee All

Poonawallas turned down $1 billion offer

2 min read . 06:57 AM IST

Many states opt for lockdown or similar curbs as Covid-19 cases rise. Full list
2 min read . 09:05 AM IST
Rakesh Jhunjhunwala Portfolio: Experts give 'buy' tag to this pharma stock
1 min read . 09:21 AM IST

7 key takeaways from RBI Governor Shaktikanta Das speech today

1 min read . 12:05 PM IST

Sumit Jamuar, Chairman & CEO of Global Gene Corp, said the ambition with the
investment is to make an “exponential leap" into the healthcare of the future
through genomics – from discovering the next generation of drugs to precision
medicine – a task "even more critical" in the context of the COVID-19 pandemic.
“The UK is at the forefront of the genomics revolution with her Genome UK
strategy. We are delighted to be investing in cutting-edge capabilities at the
intersection of genomics and machine learning to achieve our vision," he said.
Invest India CEO Deepak Bagla said in line with Prime Minister Narendra Modi’s
vision of Ayushmaan Bharat and National Healthcare Mission, "we truly believe
that the genomic revolution will have an impact on the lives of billions. Global
Gene Corp will make this revolution a reality".
Other Indian investments announced on Monday ahead of a virtual summit
between Johnson and Modi on Tuesday include Q-Rich Creations at GBP 54
million, creating 667 UK jobs; Wipro at GBP 16 million, creating 500 jobs; I2
Agro at GBP 30 million, creating 465 jobs; Mastek creating 357 jobs; and Sterlite
Technologies at GBP 15 million, creating 150 jobs.
Some of the others on the list of Indian investments include SNVA Ventures at
GBP 10 million, creating 200 jobs; Skillmine at GBP 11 million, creating 100 jobs;
CtrlS Data Centers at GBP 10 million, creating 100 jobs; Que Processing Services
at GBP 10 million, creating 100 jobs; Cron Systems at GBP 20 million, creating
100 jobs; TVS Motors-Norton creating 89 jobs; Prime Focus Technologies
creating 70 jobs; Route Mobile at GBP 20 million, creating 50 jobs; and Goila
Butter Chicken at GBP 3 million, creating 40 jobs.